Showing results (141-150 of 188) with videos related to

Sort By:
Pageof 19
Cancer Immunology, Immunotherapy : CII|March 31, 2020
A comparative view on the expression patterns of PD-L1 and PD-1 in soft tissue sarcomasMartin F Orth, Veit Leonhard Buecklein, Eric Kampmann, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|September 6, 2016
A pilot trial of doxorubicin containing phosphatidyldiglycerol based thermosensitive liposomes in spontaneous feline soft tissue sarcomaKatja Zimmermann, Martin Hossann, Johannes Hirschberger, et al.
BMC Cancer|April 11, 2025
The impact of CT-based adipose tissue distribution and sarcopenia on treatment outcomes in patients with high-risk soft tissue sarcomaLuc M Berclaz, Dorit Di Gioia, Michael Völkl, et al.
Lancet (London, England)|August 28, 2015
Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progressionAdam E Frampton, Leandro Castellano, Teresa Colombo, et al.
Genome Medicine|February 4, 2014
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinomaLisa Evers, Pedro A Perez-Mancera, Elizabeth Lenkiewicz, et al.
Frontiers in Endocrinology|September 3, 2021
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical RationalePia Adam, Stefan Kircher, Iuliu Sbiera, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 14, 2006
Nuclear export is essential for the tumor-promoting activity of survivinShirley K Knauer, Oliver H Krämer, Thomas Knösel, et al.
Oncotarget|May 19, 2016
The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growthHarini Nivarthi, Claire Gordziel, Madeleine Themanns, et al.
Oncotarget|October 19, 2018
Correction: The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growthHarini Nivarthi, Claire Gordziel, Madeleine Themanns, et al.
BMC Cancer|March 19, 2025
LDH and hemoglobin outperform systemic inflammatory indices as prognostic factors in patients with soft tissue sarcoma undergoing neoadjuvant treatmentLuc M Berclaz, Dorit Di Gioia, Vindi Jurinovic, et al.
Pageof 19